EDNRB and metastatic neoplasm: To determine whether EDNRB expression could be correlated to metastatic disease and to other prognostic indicators, such as clinico-pathological variables and genomic alterations (specifically chromosome 3 loss), we analysed EDNRB expression in a further 33 uveal melanomas by cmRT–PCR (Figure 2).